Abstract

Glucocorticoid-induced tumor necrosis factor receptor family-related protein (TNFRSF18, CD357) is constitutively expressed on regulatory T cells (Tregs) and is inducible on effector T cells. In this report, we examine the role of glucocorticoid-induced TNF receptor family-related protein ligand (GITR-L), which is expressed by antigen presenting cells, on the development and expansion of Tregs. We found that GITR-L is dispensable for the development of naturally occurring FoxP3+ Treg cells in the thymus. However, the expansion of Treg in GITR-L−/− mice is impaired after injection of the dendritic cells (DCs) inducing factor Flt3 ligand. Furthermore, DCs from the liver of GITR-L−/− mice were less efficient in inducing proliferation of antigen-specific Treg cells in vitro than the same cells from WT littermates. Upon gene transfer of ovalbumin into hepatocytes of GITR-L−/−FoxP3(GFP) reporter mice using adeno-associated virus (AAV8-OVA) the number of antigen-specific Treg in liver and spleen is reduced. The reduced number of Tregs resulted in an increase in the number of ovalbumin specific CD8+ T effector cells. This is highly significant because proliferation of antigen-specific CD8+ cells itself is dependent on the presence of GITR-L, as shown by in vitro experiments and by adoptive transfers into GITR-L−/−Rag−/− and Rag−/− mice that had received AAV8-OVA. Surprisingly, administering αCD3 significantly reduced the numbers of FoxP3+ Treg cells in the liver and spleen of GITR-L−/− but not WT mice. Because soluble Fc-GITR-L partially rescues αCD3 induced in vitro depletion of the CD103+ subset of FoxP3+CD4+ Treg cells, we conclude that expression of GITR-L by antigen presenting cells is requisite for optimal Treg-mediated regulation of immune responses including those in response during gene transfer.

Highlights

  • CD4+CD25+FoxP3+ regulatory T cells (Treg), which develop in the thymus or can be induced in peripheral organs, control many aspects of the immune response [1,2,3,4]

  • Fmsrelated tyrosine kinase 3 ligand (Flt3L)-INDUCED EXPANSION OF TREG WAS IMPAIRED IN glucocorticoidinduced TNF receptor family-related protein ligand (GITR-L) DEFICIENT MICE DUE TO A PARTIALLY REDUCED NUMBER OF DENDRITIC CELL SUBPOPULATIONS We previously found that after administering a Fc-GITR-L fusion protein to WT mice the number of Treg cells increased, which was confirmed by studies with GITR-L transgenic mice [9,10,11, 28]

  • We found that GITR-L was dispensable for the development of naturally occurring Treg, as the number of FoxP3+ Treg cells was normal in the thymus and spleen of GITRL−/−FoxP3(GFP) mice under resting conditions (Figure 1A; Figure S1 in Supplementary Material)

Read more

Summary

Introduction

CD4+CD25+FoxP3+ regulatory T cells (Treg), which develop in the thymus or can be induced in peripheral organs, control many aspects of the immune response [1,2,3,4]. Tregs constitutively express glucocorticoid-induced tumor necrosis factor receptor familyrelated protein (GITR, TNFRSF18, CD357), which is inducible on effector T cells (Teffs) [2, 5,6,7,8]. A significantly higher proportion of FoxP3+ Tregs is found in GITR-L transgenic mouse strains, in which the expression of GITR-L is under control of the CD19- and MHC-II-promoter respectively [10, 11]. We use GITR-L−/− mice to examine the role of GITR-L in the induction of Tregs and Tregmediated suppression in response to hepatic gene transfer with the adeno-associated viral vector AAV8

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.